September 2026

Darolutamide Side Effects and How They’re Managed

By Your Health Magazine Health Information Team

You start a new prostate cancer treatment and soon notice that your usual afternoon walk feels harder, your appetite has changed, or a rash has appeared. Is the medicine responsible, the cancer itself, or another treatment you are receiving? With darolutamide, the answer is not always obvious because it is commonly used alongside androgen deprivation therapy and may also be combined with the chemotherapy drug docetaxel.

Many darolutamide side effects are manageable, but some require prompt medical attention. Knowing what to watch for—and communicating changes early—can help your oncology team address problems before they interfere significantly with treatment or everyday life.

What Is Darolutamide?

Darolutamide, sold under the brand name Nubeqa, is an androgen receptor inhibitor used to treat certain forms of prostate cancer. It blocks the activity of androgens, including testosterone, that can stimulate prostate cancer cells. It is prescribed with ongoing medical or surgical treatment that keeps testosterone levels low. In some people with metastatic prostate cancer, it is also used with docetaxel.

Because each part of a treatment plan can cause overlapping symptoms, a new problem should not automatically be attributed to darolutamide. Fatigue, hot flashes, sexual changes, muscle loss, and bone loss, for example, may be related partly to androgen deprivation therapy. Readers seeking broader context can review this overview of prostate cancer symptoms, diet, treatment, and essential facts.

Common Darolutamide Side Effects

Fatigue and reduced energy

Fatigue is among the more commonly reported darolutamide side effects when the medicine is used without chemotherapy. It may feel like persistent tiredness, weakness, slower thinking, or difficulty completing normal tasks. Cancer, poor sleep, anemia, emotional stress, and low testosterone can add to the problem.

Management usually begins with identifying contributing factors. The healthcare team may review sleep, nutrition, activity, mood, medications, and blood test results. Gentle, regular exercise—when medically appropriate—can help some people maintain strength and energy. Planning demanding activities for the time of day when energy is highest, taking short rest periods, and accepting help with errands may also make daily life easier.

Changes found on blood tests

Darolutamide may be associated with elevated liver enzymes or bilirubin and a reduced neutrophil count. These changes may not produce noticeable symptoms, which is why laboratory monitoring matters. Neutrophils are white blood cells that help fight infection. Liver-related symptoms, when they occur, can include yellowing of the skin or eyes, dark urine, unusual itching, nausea, or pain in the upper abdomen.

Keep scheduled blood tests even when you feel well. Depending on the results and overall clinical picture, the oncology team may repeat testing, look for other causes, temporarily interrupt treatment, or adjust the treatment plan. Do not stop darolutamide without speaking with the prescriber.

Rash

A darolutamide-related rash may appear as redness, small bumps, itching, dryness, or irritated patches. Mild cases may be managed with skin care measures recommended by the cancer team, such as fragrance-free moisturizers, gentle cleansers, loose clothing, and protection from excessive heat or sun exposure.

Report a new or spreading rash promptly rather than treating it independently. Urgent evaluation is needed if the rash is painful, blistering, peeling, accompanied by fever, or involves the mouth, eyes, or genitals.

Pain in the arms or legs

Some people report pain in an extremity. Because limb pain can also result from arthritis, injury, blood clots, nerve problems, or cancer involving the bones, persistent or severe pain deserves evaluation. The clinician may assess its location, timing, swelling, tenderness, and relationship to movement before recommending appropriate relief.

Side Effects When Darolutamide Is Combined With Docetaxel

When darolutamide is given with docetaxel, the overall side-effect pattern changes. Common concerns can include constipation, rash, decreased appetite, weight changes, high blood pressure, bleeding, anemia, altered blood sugar, low blood cell counts, liver test abnormalities, and low calcium. Many of these effects may be influenced substantially by chemotherapy or the combined treatment plan.

Management may include regular blood counts, liver tests, blood pressure checks, attention to hydration and nutrition, and medicines prescribed for specific symptoms. Fever is especially important during chemotherapy because a low neutrophil count can make infections more dangerous. Ask the oncology team in advance which temperature or symptoms should trigger an immediate call.

Serious Risks to Know About

Heart-related problems

Darolutamide has been associated with ischemic heart disease, which occurs when the heart muscle does not receive enough blood and oxygen. Before and during treatment, clinicians may address high blood pressure, diabetes, elevated cholesterol, smoking, and other cardiovascular risk factors.

Seek emergency help for chest pressure or pain, sudden shortness of breath, cold sweats, faintness, or discomfort that spreads to the arm, shoulder, back, neck, or jaw. People with existing heart disease may benefit from coordinated care involving their oncologist, primary care clinician, and cardiologist.

Seizures

Seizures are uncommon but have occurred in people taking darolutamide. Tell the prescriber about previous seizures, stroke, brain injury, brain tumors, or medicines that may affect seizure risk. A seizure or unexplained loss of consciousness requires immediate medical evaluation. Until the situation is assessed, avoid activities in which a sudden loss of consciousness could seriously harm you or others.

Falls and fractures

Darolutamide is often part of a broader hormone treatment plan that can affect muscle strength and bone health over time. Tell the care team about falls, balance changes, new weakness, or sudden bone pain. Depending on individual risk, clinicians may consider a bone health assessment, supervised exercise, physical therapy, fall-prevention strategies, or other treatment.

How the Oncology Team Manages Side Effects

Side-effect management is individualized and may involve:

Reviewing when symptoms began and how they affect eating, walking, sleep, work, and self-care.
Checking blood counts, liver function, blood pressure, blood sugar, or other measurements.
Treating contributing problems such as dehydration, infection, anemia, constipation, or poor nutrition.
Temporarily holding or medically adjusting cancer treatment when a reaction is severe or intolerable.
Coordinating care with a pharmacist, dietitian, cardiologist, physical therapist, or other professional.

Bring an updated list of prescription medicines, over-the-counter drugs, vitamins, and supplements to every appointment. Darolutamide can interact with certain medications, and interactions may either alter its effectiveness or increase side effects. A pharmacist or prescribing clinician should review proposed additions before you start them.

When to Seek Care

Contact your oncology team promptly for a new rash, worsening fatigue, persistent vomiting or constipation, poor fluid intake, unusual bleeding, yellow skin or eyes, dark urine, signs of infection, increasing weakness, falls, or symptoms that interfere with normal activities. During chemotherapy, fever or chills may require urgent assessment even if you otherwise feel well.

Call emergency services for chest pain, severe trouble breathing, a seizure, loss of consciousness, sudden confusion, uncontrolled bleeding, or a severe blistering or peeling rash. Your medical oncologist is the main professional to contact about darolutamide side effects, while an oncology pharmacist can help evaluate medication interactions. General information about recognizing and responding to drug reactions and medication side effects can also help patients prepare questions for their care team.

Keep a simple symptom diary noting when each problem occurs, how long it lasts, and what makes it better or worse. Early, specific reporting gives the oncology team the best opportunity to manage side effects while protecting the goals of prostate cancer treatment.